Loading…
India Infra Updates on WhatsApp
Join the Tenderkart WhatsApp channel for India Tender Updates
Loading…
Tender ID
Eligibility, documents, scope and key termsEligibility, required documents, scope of work and key terms of this tender, in one click.
| # | Company | Status |
|---|---|---|
| 1 | Admitted-Fee/PreQual/Technical/Finance | Admitted-Fee/PreQual/Technical/Finance |
| 2 | Admitted-Fee/PreQual/Technical/Finance | Admitted-Fee/PreQual/Technical/Finance |
| 3 | Admitted-Fee/PreQual/Technical/Finance | Admitted-Fee/PreQual/Technical/Finance |
| 4 | Admitted-Fee/PreQual/Technical/Finance | Admitted-Fee/PreQual/Technical/Finance |
Tender Value
Refer Docs
EMD Value
₹62,406
Closing Date
27 Sept 2023, 2:30 pmClosed
Eligibility, documents, scope and key termsEligibility, required documents, scope of work and key terms of this tender, in one click.
ASSISTANT PURCHASE OFFICER
CPU, V.S., BHAWAN, ANUSHAKTINAGAR, MUMBAI-94
SUPPLY OF LINAGLIPTIN 5 MG TAB
2023_DPS_764687_1
DPS/CPU/04/MED/41463/PT
Open Tender
Drugs and Pharmaceutical Products
Item Rate
45 days
ASO, BARC HOSPITAL STORES, ANUSHAKTI NAGAR, MUMBAI
1.RATE CONTRACT FOR THE PERIOD OF 1 YEAR 2) PERFORMANCE SECURITY
DEPOSIT BANK GUARANTEE WILL BE FOR 10 PERCENT OF CONTRACT VALUE
OF 25000 TAB OF ITEM INSTEAD OF TENDERING QUATITY OF
100000 TAB
5 documents required · 5 mandatory
₹0
₹62,406
Yes
29 Sept 2023
11 Aug 2023
29 Sept 2023
11 Aug 2023
27 Sept 2023
11 Aug 2023
LINAGLIPTIN 5 MG TABLET
ACUGEN LIFESCIENCES PVT. LTD.
TORRENT PHARMACEUTICALS LTD
Boehringer Ingelheim India Private Limited
stage.html
html • 0.02 MB
boq_comp_chart.xlsx
xlsx
Tap a document below to read it instantly. You can also download everything as a ZIP if you prefer.
details.html
html • 0.03 MB
Download all tender documents and submit your bid
Disclaimer: TenderKart has made every reasonable effort to ensure that the information on this page is accurate and authentic, however it cannot be held liable for any third-party claims or losses or any damages. TenderKart makes no warranty, expressed or implied, as to the results obtained from the use of this information. If you notice any error or omission, please let us know at .